Abstract
Summary
LPI (LP Information)' newest research report, the “Clinical Genomics Software Industry Forecast” looks at past sales and reviews total world Clinical Genomics Software sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Genomics Software sales for 2023 through 2029. With Clinical Genomics Software sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Genomics Software industry.
This Insight Report provides a comprehensive analysis of the global Clinical Genomics Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Genomics Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Genomics Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Genomics Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Genomics Software.
The global Clinical Genomics Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Clinical Genomics Software players cover Agilent Technologies, QIAGEN Digital Insights, Fabric Genomics, Congenica, BioDiscovery and PierianDx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Genomics Software market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Web-based
Cloud-based
Segmentation by application
Hospitals and Health Systems
Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
QIAGEN Digital Insights
Fabric Genomics
Congenica
BioDiscovery
PierianDx
This Insight Report provides a comprehensive analysis of the global Clinical Genomics Software landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Genomics Software portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Genomics Software market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Genomics Software and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Genomics Software.
The global Clinical Genomics Software market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Clinical Genomics Software is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Clinical Genomics Software players cover Agilent Technologies, QIAGEN Digital Insights, Fabric Genomics, Congenica, BioDiscovery and PierianDx, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Genomics Software market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Web-based
Cloud-based
Segmentation by application
Hospitals and Health Systems
Research Organizations
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Agilent Technologies
QIAGEN Digital Insights
Fabric Genomics
Congenica
BioDiscovery
PierianDx
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Clinical Genomics Software Market Size 2018-2029
2.1.2 Clinical Genomics Software Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Clinical Genomics Software Segment by Type
2.2.1 Web-based
2.2.2 Cloud-based
2.3 Clinical Genomics Software Market Size by Type
2.3.1 Clinical Genomics Software Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Clinical Genomics Software Market Size Market Share by Type (2018-2023)
2.4 Clinical Genomics Software Segment by Application
2.4.1 Hospitals and Health Systems
2.4.2 Research Organizations
2.4.3 Others
2.5 Clinical Genomics Software Market Size by Application
2.5.1 Clinical Genomics Software Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Clinical Genomics Software Market Size Market Share by Application (2018-2023)
3 Clinical Genomics Software Market Size by Player
3.1 Clinical Genomics Software Market Size Market Share by Players
3.1.1 Global Clinical Genomics Software Revenue by Players (2018-2023)
3.1.2 Global Clinical Genomics Software Revenue Market Share by Players (2018-2023)
3.2 Global Clinical Genomics Software Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Clinical Genomics Software by Regions
4.1 Clinical Genomics Software Market Size by Regions (2018-2023)
4.2 Americas Clinical Genomics Software Market Size Growth (2018-2023)
4.3 APAC Clinical Genomics Software Market Size Growth (2018-2023)
4.4 Europe Clinical Genomics Software Market Size Growth (2018-2023)
4.5 Middle East & Africa Clinical Genomics Software Market Size Growth (2018-2023)
5 Americas
5.1 Americas Clinical Genomics Software Market Size by Country (2018-2023)
5.2 Americas Clinical Genomics Software Market Size by Type (2018-2023)
5.3 Americas Clinical Genomics Software Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Clinical Genomics Software Market Size by Region (2018-2023)
6.2 APAC Clinical Genomics Software Market Size by Type (2018-2023)
6.3 APAC Clinical Genomics Software Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Clinical Genomics Software by Country (2018-2023)
7.2 Europe Clinical Genomics Software Market Size by Type (2018-2023)
7.3 Europe Clinical Genomics Software Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Clinical Genomics Software by Region (2018-2023)
8.2 Middle East & Africa Clinical Genomics Software Market Size by Type (2018-2023)
8.3 Middle East & Africa Clinical Genomics Software Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Clinical Genomics Software Market Forecast
10.1 Global Clinical Genomics Software Forecast by Regions (2024-2029)
10.1.1 Global Clinical Genomics Software Forecast by Regions (2024-2029)
10.1.2 Americas Clinical Genomics Software Forecast
10.1.3 APAC Clinical Genomics Software Forecast
10.1.4 Europe Clinical Genomics Software Forecast
10.1.5 Middle East & Africa Clinical Genomics Software Forecast
10.2 Americas Clinical Genomics Software Forecast by Country (2024-2029)
10.2.1 United States Clinical Genomics Software Market Forecast
10.2.2 Canada Clinical Genomics Software Market Forecast
10.2.3 Mexico Clinical Genomics Software Market Forecast
10.2.4 Brazil Clinical Genomics Software Market Forecast
10.3 APAC Clinical Genomics Software Forecast by Region (2024-2029)
10.3.1 China Clinical Genomics Software Market Forecast
10.3.2 Japan Clinical Genomics Software Market Forecast
10.3.3 Korea Clinical Genomics Software Market Forecast
10.3.4 Southeast Asia Clinical Genomics Software Market Forecast
10.3.5 India Clinical Genomics Software Market Forecast
10.3.6 Australia Clinical Genomics Software Market Forecast
10.4 Europe Clinical Genomics Software Forecast by Country (2024-2029)
10.4.1 Germany Clinical Genomics Software Market Forecast
10.4.2 France Clinical Genomics Software Market Forecast
10.4.3 UK Clinical Genomics Software Market Forecast
10.4.4 Italy Clinical Genomics Software Market Forecast
10.4.5 Russia Clinical Genomics Software Market Forecast
10.5 Middle East & Africa Clinical Genomics Software Forecast by Region (2024-2029)
10.5.1 Egypt Clinical Genomics Software Market Forecast
10.5.2 South Africa Clinical Genomics Software Market Forecast
10.5.3 Israel Clinical Genomics Software Market Forecast
10.5.4 Turkey Clinical Genomics Software Market Forecast
10.5.5 GCC Countries Clinical Genomics Software Market Forecast
10.6 Global Clinical Genomics Software Forecast by Type (2024-2029)
10.7 Global Clinical Genomics Software Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 Agilent Technologies
11.1.1 Agilent Technologies Company Information
11.1.2 Agilent Technologies Clinical Genomics Software Product Offered
11.1.3 Agilent Technologies Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Agilent Technologies Main Business Overview
11.1.5 Agilent Technologies Latest Developments
11.2 QIAGEN Digital Insights
11.2.1 QIAGEN Digital Insights Company Information
11.2.2 QIAGEN Digital Insights Clinical Genomics Software Product Offered
11.2.3 QIAGEN Digital Insights Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 QIAGEN Digital Insights Main Business Overview
11.2.5 QIAGEN Digital Insights Latest Developments
11.3 Fabric Genomics
11.3.1 Fabric Genomics Company Information
11.3.2 Fabric Genomics Clinical Genomics Software Product Offered
11.3.3 Fabric Genomics Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Fabric Genomics Main Business Overview
11.3.5 Fabric Genomics Latest Developments
11.4 Congenica
11.4.1 Congenica Company Information
11.4.2 Congenica Clinical Genomics Software Product Offered
11.4.3 Congenica Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Congenica Main Business Overview
11.4.5 Congenica Latest Developments
11.5 BioDiscovery
11.5.1 BioDiscovery Company Information
11.5.2 BioDiscovery Clinical Genomics Software Product Offered
11.5.3 BioDiscovery Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 BioDiscovery Main Business Overview
11.5.5 BioDiscovery Latest Developments
11.6 PierianDx
11.6.1 PierianDx Company Information
11.6.2 PierianDx Clinical Genomics Software Product Offered
11.6.3 PierianDx Clinical Genomics Software Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 PierianDx Main Business Overview
11.6.5 PierianDx Latest Developments
12 Research Findings and Conclusion